Welcome to ImQuest BioSciences

ImQuest BioSciences is a preclinical contract research and development company that evaluates the potential of new and novel pharmaceutical products. We provide expert laboratory research services to define the efficacy and toxicity of pharmaceutical products and specialize in the development of drugs, vaccines and biologic products for the treatment and prevention of infectious disease, cancer and inflammatory disease. We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. We understand that each product and client is unique and we strive to provide effective solutions. Learn More

What's New

  • Anti-Dengue antibodies enhance Zika virus infection

    As part of our ViroSENS program, ImQuest BioSciences has established an anti-Zika virus cytoprotection assay for multiple strains of Zika virus in multiple cell types.

    Read More


  • HIV Research For Prevention (HIV-R4P)

    October 18-21, 2016
    Chicago, IL
  • American Association of Pharmaceutical Science

    November 13-17, 2016
    Denver, CO

Meet the Team

Robert Buckheit

Robert W. Buckheit, Jr., Ph.D.

President and CSO

Dr. Buckheit received a B.S. in Biology from Lehigh University in 1982, a Ph.D. in Microbiology and Immunology from Duke University in 1986, and

Read More